摘要
目的探讨肠康颗粒治疗轻中度溃疡性结肠炎的临床疗效。方法选取医院2013年12月至2015年3月收治的患者116例,按随机数字表法分为试验组和对照组,各58例。对照组患者给予柳氮磺嘧啶,每次1 g,3次/日;试验组患者均给予肠康颗粒,每次1袋,3次/日,均以8周为1个疗程。结果治疗后,试验组临床症状积分为(2.24±1.64)分,显著低于对照组的(3.73±1.82)分(P<0.05);试验组肠镜下评分为(2.73±1.82)分,显著低于对照组的(3.50±2.01)分(P<0.05);试验组治愈率和总有效率分别为29.31%和93.10%,显著高于对照组的18.97%和68.97%(P<0.05)。结论肠康颗粒可改善轻中度溃疡性结肠炎患症状,疗效显著,安全性高,值得临床推广。
Objective To investigate the clinical efficacy of Changkang Granules in treating mild to moderate ulcerative colitis. Methods 116 cases of mild to moderate ulcer colitis in the hospital from December 2013 to March 2015 were randomly divided into the experi-mental group and the control group according to the random number table method,58 cases in each group. The control group was treat-ed with sulfasalazine pyrimidine,1 g/time,3 times/day. The experimental group was given 1 bag/time,3 times/day,8 weeks for 1 course of treatment. Results After treatment,the clinical symptoms of the experimental group was (2. 24 ± 1. 64) points,which was obviously lower than(3. 73 ± 1. 82) points of the control group( P < 0. 05);the colonoscopy scores of the experimental group was (2. 73 ± 1. 82) points,which was obviously lower than (3. 50 ± 2. 01) points of the control group( P < 0. 05);the cure rate and total effective rate of the experimental group were 29. 31% and 93. 10% respectively,which were obviously higher than 18. 97% and 68. 97% of the control group( P < 0. 05). Conclusion Changkang Granules can improve the symptoms of mild to moderate ulcerative colitis,the efficacy is remarkable,it is safe and worthy of clinical promotion.
出处
《中国药业》
CAS
2015年第22期210-212,共3页
China Pharmaceuticals
关键词
肠康颗粒
轻中度溃疡性结肠炎
疗效
Changkang Granules
mild to moderate ulcerative colitis
efficacy
